血栓闭塞性脉管炎合并慢性肢体缺血患者血管内血管成形术后早期和晚期结局的系统评价与Meta分析
该系统评价与Meta分析纳入15项研究、601例患者、402例血管内手术(416条肢体),评估血栓闭塞性脉管炎合并慢性肢体缺血患者血管内血管成形术的早期和晚期结局。汇总技术成功率为86%(范围81.1%-90.3%),无院内死亡,12个月一期通畅率65.7%、36个月50.7%,12个月保肢率94.1%、36个月89.1%。作者认为该治疗安全、并发症率低,技术成功率和晚期结局可接受。
要点
- 汇总技术成功率为86%(范围81.1%-90.3%),无院内死亡。
- 12个月一期通畅率65.7%,36个月降至50.7%。
- 12个月保肢率94.1%,36个月为89.1%。
核心结论
- 血栓闭塞性脉管炎合并慢性肢体缺血患者行血管内血管成形术与良好的安全性和低并发症率相关。
- 技术成功率和晚期结局可接受。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Scopus和Cochrane Library,纳入截至2021年12月报告的研究。
- 纳入15项研究(11项仅血管内治疗,4项血管内与开放手术),共601例患者、402例血管内手术(416条肢体)。
- 评估早期结局(死亡和技术成功)和晚期结局(一期/二期通畅率和保肢率)。
主要发现
- 血管成形术加支架占7.2%,血管成形术加溶栓占3.7%。
- 临床表现间歇性跛行(II-III期)占7.9%,严重缺血(IV-VI期)占92.1%。
- 大多数患者病变位于膝下,5例有上肢病变。
- 汇总技术成功率为86%(范围81.1%-90.3%),无院内死亡;并发症包括穿孔(1.9%)、伤口并发症(2.2%)和远端栓塞(0.2%)。
- 一期通畅率12个月为65.7%(范围52.7%-77.6%),36个月为50.7%(范围23.3%-77.9%);二期通畅率12个月为76.2%(范围57.5%-90.8%),36个月为64.5%(范围32.3%-90.6%);保肢率12个月为94.1%(范围90.7%-96.7%),36个月为89.1%(范围80.6%-95.4%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No consensus has yet been reached regarding the optimal treatment of patients with thromboangiitis obliterans (TO) and chronic limb ischemia. In the present study, we aimed to summarize the results on endovascular treatment of such patients. METHODS: We performed a meta-analysis using the following databases: PubMed, Scopus, and the Cochrane Library. The eligible studies had been reported up to December 2021 and had evaluated endovascular angioplasty to treat patients with TO and chronic limb ischemia. The early (mortality and technical success) and late (primary/secondary patency and limb salvage) outcomes were evaluated. StatsDirect (StatsDirect Ltd, Merseyside, UK) was used for the statistical analysis. RESULTS: Overall, 15 eligible studies were included (only endovascular in 11 studies and both endovascular and open repair in 4 studies). Among 601 patients, 402 endovascular procedures (416 limbs) were recorded (angioplasty plus stenting for 7.2% and angioplasty plus thrombolysis for 3.7%). The clinical presentation was intermittent claudication (stage II-III) for 7.9% of the patients and critical ischemia (stage IV-VI) for 92.1% of the patients. Most of the patients had had lesions below the knee, and five had had upper extremity lesions. The pooled technical success rate was 86% (range, 81.1%-90.3%), with no in-hospital mortality. The other complications included perforations (1.9%), wound complications (2.2%), and distal embolism (0.2%). Primary patency was 65.7% (range, 52.7%-77.6%) at 12 months and 50.7% (range, 23.3%-77.9%) at 36 months. Secondary patency was 76.2% (range, 57.5%-90.8%) at 12 months and 64.5% (range, 32.3%-90.6%) at 36 months. The limb salvage rate was 94.1% (range, 90.7%-96.7%) at 12 months and 89.1% (range, 80.6%-95.4%) at 36 months. CONCLUSIONS: Endovascular angioplasty for patients with TO and chronic limb ischemia was associated with optimal safety and low complication rates. The technical success and late outcomes were acceptable.
引用
- Galyfos G, Liakopoulos D, Chamzin A, et al. A systematic review and meta-analysis of early and late outcomes after endovascular angioplasty among patients with thromboangiitis obliterans and chronic limb ischemia. J Vasc Surg. 2022. PMID: 36174815. doi:10.1016/j.jvs.2022.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。